These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31549772)

  • 1. What Does the Patient Global Health Assessment in Rheumatoid Arthritis Really Tell Us? Contribution of Specific Dimensions of Health-Related Quality of Life.
    Craig ET; Perin J; Zeger S; Curtis JR; Bykerk VP; Bingham CO; Bartlett SJ
    Arthritis Care Res (Hoboken); 2020 Nov; 72(11):1571-1578. PubMed ID: 31549772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different Rating of Global Rheumatoid Arthritis Disease Activity in Rheumatoid Arthritis Patients With Multiple Morbidities.
    Radner H; Yoshida K; Tedeschi S; Studenic P; Frits M; Iannaccone C; Shadick NA; Weinblatt M; Aletaha D; Smolen JS; Solomon DH
    Arthritis Rheumatol; 2017 Apr; 69(4):720-727. PubMed ID: 27860467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between Patient Global Assessment scores and pain, physical function, and fatigue in rheumatoid arthritis: a post hoc analysis of data from phase 3 trials of tofacitinib.
    Strand V; Kaine J; Alten R; Wallenstein G; Diehl A; Shi H; Germino R; Murray CW
    Arthritis Res Ther; 2020 Oct; 22(1):243. PubMed ID: 33059710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tofacitinib with conventional synthetic disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: Patient-reported outcomes from a Phase 3 randomized controlled trial.
    Li Z; An Y; Su H; Li X; Xu J; Zheng Y; Li G; Kwok K; Wang L; Wu Q
    Int J Rheum Dis; 2018 Feb; 21(2):402-414. PubMed ID: 29314645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Patient's Global Assessment on Achieving Remission in Patients With Rheumatoid Arthritis: A Multinational Study Using the METEOR Database.
    Ferreira RJO; Carvalho PD; Ndosi M; Duarte C; Chopra A; Murphy E; van der Heijde D; Machado PM; da Silva JAP
    Arthritis Care Res (Hoboken); 2019 Oct; 71(10):1317-1325. PubMed ID: 30821895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to remission in swollen joints is far faster than patient reported outcomes in rheumatoid arthritis: results from the Ontario Best Practices Research Initiative (OBRI).
    Pope JE; Rampakakis E; Movahedi M; Cesta A; Sampalis JS; Bombardier C;
    Rheumatology (Oxford); 2021 Feb; 60(2):717-727. PubMed ID: 32789456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discordance between the patient's and physician's global assessment in rheumatoid arthritis: Data from the REAL study-Brazil.
    Guimarães MFBR; Pinto MRDC; Resende GG; Machado CJ; Vargas-Santos AB; Amorim RBC; Gomides APM; Albuquerque CP; Bértolo MB; Júnior PL; Santos IA; Giorgi RDN; Saciloto NC; Radominski SC; Borghi FM; Bonfiglioli KR; Silva HCD; Sauma MFLDC; Sauma ML; Medeiros JB; Pereira IA; Castro GRW; Brenol CV; Xavier RM; Mota LMH; Castelar-Pinheiro GDR
    PLoS One; 2020; 15(3):e0230317. PubMed ID: 32168350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of Patient's Global Assessment of Disease Activity and Physician's Global Assessment of Disease Activity in patients with rheumatoid arthritis: A post hoc analysis of overall and Japanese results from phase 3 clinical trials.
    Kaneko Y; Takeuchi T; Cai Z; Sato M; Awakura K; Gaich C; Zhu B; Guo J; Tanaka Y
    Mod Rheumatol; 2018 Nov; 28(6):960-967. PubMed ID: 29278339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study.
    Keystone EC; Taylor PC; Tanaka Y; Gaich C; DeLozier AM; Dudek A; Zamora JV; Cobos JAC; Rooney T; Bono S; Arora V; Linetzky B; Weinblatt ME
    Ann Rheum Dis; 2017 Nov; 76(11):1853-1861. PubMed ID: 28798049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of frailty on patient global assessment in rheumatoid arthritis.
    Suzuki M; Asai S; Sobue Y; Ohashi Y; Koshima H; Okui N; Ishikawa H; Takahashi N; Terabe K; Kishimoto K; Hattori K; Imagama S; Kojima T
    Geriatr Gerontol Int; 2022 May; 22(5):399-404. PubMed ID: 35365932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of physician and patient global assessments over time in patients with rheumatoid arthritis: a retrospective analysis from the RADIUS cohort.
    Markenson JA; Koenig AS; Feng JY; Chaudhari S; Zack DJ; Collier D; Weaver A
    J Clin Rheumatol; 2013 Sep; 19(6):317-23. PubMed ID: 23965479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient and physician perspectives on the impact of health-related quality of life in Mexican patients with ANCA-associated vasculitis.
    Hinojosa-Azaola A; Jiménez-González A; Alcocer-Castillejos N
    Rheumatol Int; 2018 Apr; 38(4):631-640. PubMed ID: 29247347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tofacitinib in Combination With Conventional Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis: Patient-Reported Outcomes From a Phase III Randomized Controlled Trial.
    Strand V; Kremer JM; Gruben D; Krishnaswami S; Zwillich SH; Wallenstein GV
    Arthritis Care Res (Hoboken); 2017 Apr; 69(4):592-598. PubMed ID: 27565000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with anxiety and depression in rheumatoid arthritis patients: a cross-sectional study.
    Uda M; Hashimoto M; Uozumi R; Torii M; Fujii T; Tanaka M; Furu M; Ito H; Terao C; Yamamoto W; Sugihara G; Nakagami Y; Mimori T; Nin K
    Adv Rheumatol; 2021 Oct; 61(1):65. PubMed ID: 34715944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiety impacts rheumatoid arthritis symptoms and health-related quality of life even at low levels.
    DiRenzo DD; Craig ET; Bingham Iii CO; Bartlett SJ
    Clin Exp Rheumatol; 2020; 38(6):1176-1181. PubMed ID: 32141436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced toxicity and patient reported outcomes in rheumatoid arthritis patients following intensive treated-to-target strategy: does ceasing therapy due to toxicity worsen outcomes in long term?
    Wabe N; Sorich MJ; Wechalekar MD; Cleland LG; McWilliams L; Lee A; Hall C; Spargo L; Metcalf R; Proudman SM; Wiese MD
    Int J Clin Pract; 2016 Apr; 70(4):340-50. PubMed ID: 26987888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Global Assessment of Disease Activity and Radiographic Progression in Early Arthritis: Three-Year Results From the ESPOIR Cohort.
    Ferreira RJO; Fautrel B; Saraux A; Gaujoux-Viala C; Rat AC; Guillemin F; da Silva JAP; Dougados M; Gossec L
    Arthritis Care Res (Hoboken); 2021 Sep; 73(9):1300-1305. PubMed ID: 32339449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of depression, anxiety, fatigue, and fibromyalgia on the evaluation of the remission status in patients with rheumatoid arthritis.
    Inanc N; Yilmaz-Oner S; Can M; Sokka T; Direskeneli H
    J Rheumatol; 2014 Sep; 41(9):1755-60. PubMed ID: 25086073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT.
    Strand V; Pope J; Tundia N; Friedman A; Camp HS; Pangan A; Ganguli A; Fuldeore M; Goldschmidt D; Schiff M
    Arthritis Res Ther; 2019 Dec; 21(1):272. PubMed ID: 31815649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.